Central Asset Investments & Management Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,200	Closed	-$96K	–	71
2024 Q4	$96K	Buy	+14,200	New	+$96K	0.06%	75